Recently, Ross et al. demonstrated that there may be a thrombotic risk associated with increased mitochondrial mass in platelets from MPN patients, although no correlation between the variant allele frequency (VAF) of JAK2 V617F (measured in leukocyte DNA) and mitochondrial mass in platelets was found [30]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.